Opportunity Information: Apply for PAR 24 213
The NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity is an NIH K99/R00 program (Funding Opportunity Number PAR-24-213) that helps advanced postdoctoral researchers move from a mentored postdoc role into a fully independent, tenure-track (or equivalent) faculty position while building a long-term research program focused on Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The core idea is to create a pipeline of strong, independent investigators from diverse backgrounds, in line with NIH's stated interest in promoting diversity in the biomedical research workforce. This award is structured to reduce the common gap that occurs when a postdoc is ready to launch an independent lab but still needs time, funding stability, and a clear plan to transition into an independent appointment.
The mechanism has two linked phases. The K99 phase is the mentored career development period that supports the candidate while they finish advanced postdoctoral training and complete the final steps needed to become independent. The R00 phase is the independent research support period that begins after the awardee secures an independent faculty position, with the intent of enabling the recipient to establish their own research direction, publish as a senior author, and compete successfully for larger, long-term NIH funding. In other words, the program is explicitly designed around a "bridge" from postdoc to independence, with NIH support on both sides of that transition.
A key restriction in this specific announcement is the clinical trial limitation: it is for "Independent Clinical Trial Not Allowed." That means the proposed research plan cannot include the awardee leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. However, the FOA does allow the applicant to gain experience working on a clinical trial as part of their training if the trial is led by the mentor or a co-mentor. This is an important nuance for applicants working in human-focused AD/ADRD research who may need exposure to clinical research methods without being positioned as the trial leader under this award.
The opportunity sits within NIH's health research portfolio and is administered by the National Institute of Neurological Disorders and Stroke (NINDS). The activity aligns with AD/ADRD research priorities and uses the grant funding instrument type, with activity categorized under Health. The listed CFDA numbers are 93.853 and 93.866, which correspond to NIH assistance listings tied to NINDS and related neurological research funding areas.
Eligibility is broad at the organizational level, reflecting the wide range of institutions that can host either the mentored postdoctoral phase or the independent phase. Eligible applicants include many types of U.S.-based entities such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, state and local governments, special district governments, independent school districts, public housing authorities/Indian housing authorities, and federally recognized Native American tribal governments and certain tribal organizations. The FOA also highlights additional categories of eligible organizations often central to NIH diversity efforts, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and eligible federal agencies.
At the same time, there are clear boundaries around foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. That said, "foreign components" are allowed as defined in the NIH Grants Policy Statement, which generally means discrete elements of a project that take place outside the U.S. can be included when they are well-justified and meet NIH policy requirements, even though the applicant institution itself must be U.S.-based.
The opportunity is currently open with an original closing date listed as July 12, 2027, and it was created on June 24, 2024. While an award ceiling and expected number of awards are not specified in the provided listing, the overall purpose is clear: provide structured, phased NIH support to help diverse, promising AD/ADRD postdoctoral researchers make a timely jump into independent faculty roles and successfully launch independent research programs, with the additional constraint that the applicant cannot propose to lead an independent clinical trial under this particular K99/R00 announcement.Apply for PAR 24 213
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
- This funding opportunity was created on 2024-06-24.
- Applicants must submit their applications by 2027-07-12.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: 2025-2026 English for Journalists Program
Previous opportunity: Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 24 213
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 24 213) also looked into and applied for these:
| Funding Opportunity |
|---|
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 24 223 Funding Number: PAR 24 223 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Interaction Between Environmental Factors and Lewy Body Dementia (R01 - Clinical Trial Not Allowed) Apply for PAR 24 249 Funding Number: PAR 24 249 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional) Apply for RFA MH 25 195 Funding Number: RFA MH 25 195 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Community-Based Maternal Behavioral Health Services Program Apply for SM 24 013 Funding Number: SM 24 013 Agency: Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $500,000 |
| B-INSPIRE: Research on Behavioral Interventions that Promote Careers in the Biomedical Research Enterprise (R01 - Clinical Trial Not Allowed) Apply for PAR 24 230 Funding Number: PAR 24 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) Apply for PAR 24 233 Funding Number: PAR 24 233 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe (SUPPORT-TB) Activity Apply for 72061324RFA00001 Funding Number: 72061324RFA00001 Agency: Zimbabwe USAID-Harare Category: Health Funding Amount: $29,000,000 |
| Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) Apply for RFA AG 25 010 Funding Number: RFA AG 25 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed) Apply for PAR 24 250 Funding Number: PAR 24 250 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Enhancement Awards to Build Cross-Disciplinary Knowledge and Skills for Comparative Studies of Human and Nonhuman Primate Species with Differing Life Spans (K18 Clinical Trial Not Allowed) Apply for RFA AG 25 028 Funding Number: RFA AG 25 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Supply Chain Madagascar USAID MAHENIKA Apply for 72068724RFA00005 Funding Number: 72068724RFA00005 Agency: Madagascar USAID-Antananarivo Category: Health Funding Amount: $45,000,000 |
| Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed) Apply for RFA AI 24 045 Funding Number: RFA AI 24 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional Apply for RFA HG 24 026 Funding Number: RFA HG 24 026 Agency: National Institutes of Health Category: Health Funding Amount: $850,000 |
| Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed) Apply for PAR 24 240 Funding Number: PAR 24 240 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U24 Clinical Trial Not Allowed) Apply for PAR 24 241 Funding Number: PAR 24 241 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementing and Evaluating Patient-Centered Clinical Decision Support Strategies in Real-World Settings(U18) Apply for RFA HS 24 003 Funding Number: RFA HS 24 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| SUstaining Control the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) Apply for RFI7206562024SUCESSO Funding Number: RFI7206562024SUCESSO Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $155,000,000 |
| Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) Apply for RFA AG 25 020 Funding Number: RFA AG 25 020 Agency: National Institutes of Health Category: Health Funding Amount: $925,000 |
| TB-HIV Community-Led Monitoring Apply for 72049223APS00001 5 Funding Number: 72049223APS00001 5 Agency: Philippines USAID-Manila Category: Health Funding Amount: $2,500,000 |
| USAID iDOT PRE-APPLICATION CONFERENCE Apply for 720620NOTICE240009 Funding Number: 720620NOTICE240009 Agency: Nigeria USAID-Abuja Category: Health Funding Amount: $90,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 24 213", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
